1-, 3-Month DAPT Regimens Show Similar Results to 12-Month DAPT in High-Bleeding-Risk Patients
Shorter dual antiplatelet (DAPT) regimens for high-bleeding-risk (HBR) patients who underwent successful percutaneous coronary intervention (PCI) resulted in similar bleeding and thrombotic outcomes to the standard 12-month DAPT regimen in similar patients, according to study results presented Thursday at the TCT Connect virtual conference.